SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 176.01-0.2%Dec 31 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Lundberg who wrote (29)9/26/1996 9:44:00 AM
From: Harold Engstrom   of 1686
 
Rick, thank you again for your detailed response. Jim Vincent had said he would match Avonex's data against copaxone any day, and now I can see why. Less informed reports cited a host of advantages that copaxone had, but those apparently are not true. Given a choice between beta interferon and copaxone, there really is no choice, unless the end-user is allergic to beta. Thanks again,

Harold Engstrom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News